<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37566255</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Can vitamin D be an adjuvant therapy for juvenile rheumatic diseases?</ArticleTitle><Pagination><StartPage>1993</StartPage><EndPage>2009</EndPage><MedlinePgn>1993-2009</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05411-5</ELocationID><Abstract><AbstractText>Vitamin D, known for its essential role in calcium and bone homeostasis, has multiple effects beyond the skeleton, including regulation of immunity and modulation of autoimmune processes. Several reports have shown suboptimal serum 25 hydroxyvitamin D [25(OH)D] levels in people with different inflammatory and autoimmune rheumatic conditions, and an association between 25(OH)D levels, disease activity and outcomes. Although most available data pertain to adults, insights often are extended to children. Juvenile rheumatic diseases (JRDs) are a significant health problem during growth because of their complex pathogenesis, chronic nature, multisystemic involvement, and long-term consequences. So far, there is no definitive or clear evidence to confirm the preventive or therapeutic effect of vitamin D supplementation in JRDs, because results from randomized controlled trials (RCTs) have produced inconsistent outcomes. This review aims to explore and discuss the potential role of vitamin D in treating selected JRDs. Medline/PubMed, EMBASE, and Scopus were comprehensively searched in June 2023 for any study on vitamin D supplementary role in treating the most common JRDs. We used the following keywords: "vitamin D" combined with the terms "juvenile idiopathic arthritis", "juvenile systemic scleroderma", "juvenile systemic lupus erythematosus", "juvenile inflammatory myopathies", "Behcet disease", "periodic fever syndromes" and "juvenile rheumatic diseases". Observational studies have found that serum 25(OH)D concentrations are lower in juvenile idiopathic arthritis, juvenile systemic lupus erythematosus, juvenile systemic scleroderma, Behcet disease and proinflammatory cytokine concentrations are higher. This suggests that vitamin D supplementation might be beneficial, however, current data are insufficient to confirm definitively the complementary role of vitamin D in the treatment of JRDs. Considering the high prevalence of vitamin D deficiency worldwide, children and adolescents should be encouraged to supplement vitamin D according to current recommendations. More interventional studies, especially well-designed RCTs, assessing the dose-response effect and adjuvant effect in specific diseases, are needed to determine the potential significance of vitamin D in JRDs treatment.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stawicki</LastName><ForeName>Maciej K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0002-4267-1887</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, University Children's Clinical Hospital in Bialystok, Waszyngtona Street 17, 15274, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abramowicz</LastName><ForeName>Pawe&#x142;</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6150-0971</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, University Children's Clinical Hospital in Bialystok, Waszyngtona Street 17, 15274, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokolowska</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0002-2242-603X</Identifier><AffiliationInfo><Affiliation>University Children's Clinical Hospital in Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wo&#x142;ejszo</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8305-1852</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, University Children's Clinical Hospital in Bialystok, Waszyngtona Street 17, 15274, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>William B</ForeName><Initials>WB</Initials><Identifier Source="ORCID">0000-0002-1439-3285</Identifier><AffiliationInfo><Affiliation>Sunlight, Nutrition, and Health Research Center, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konstantynowicz</LastName><ForeName>Jerzy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1230-332X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, University Children's Clinical Hospital in Bialystok, Waszyngtona Street 17, 15274, Bialystok, Poland. jurekonstant@o2.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C537703">Juvenile systemic scleroderma</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="Y">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Idiopathic inflammatory myopathies</Keyword><Keyword MajorTopicYN="N">Juvenile idiopathic arthritis</Keyword><Keyword MajorTopicYN="N">Juvenile systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Juvenile systemic scleroderma</Keyword><Keyword MajorTopicYN="N">Periodic fever syndromes</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37566255</ArticleId><ArticleId IdType="pmc">PMC10495493</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05411-5</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05411-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062&#x2013;2072. doi: 10.1172/JCI29449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29449</ArticleId><ArticleId IdType="pmc">PMC1523417</ArticleId><ArticleId IdType="pubmed">16886050</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams SA, Coss-Bu JA, Tiosano D. Vitamin D: effects on childhood health and disease. Nat Rev Endocrinol. 2013;9(3):162&#x2013;170. doi: 10.1038/nrendo.2012.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.259</ArticleId><ArticleId IdType="pubmed">23381033</ArticleId></ArticleIdList></Reference><Reference><Citation>Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255&#x2013;1260. doi: 10.3945/ajcn.2009.29094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2009.29094</ArticleId><ArticleId IdType="pubmed">20219962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40:1109&#x2013;1151. doi: 10.1210/er.2018-00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00126</ArticleId><ArticleId IdType="pmc">PMC6626501</ArticleId><ArticleId IdType="pubmed">30321335</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren RW, Perez MD, Wilking AP, Myones BL. Pediatric rheumatic diseases. Pediatr Clin North Am. 1994;41:783&#x2013;818. doi: 10.1016/s0031-3955(16)38808-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0031-3955(16)38808-3</ArticleId><ArticleId IdType="pubmed">8047370</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann LJ, Hedrich CM. Is it time to re-think juvenile-onset rheumatic and musculoskeletal diseases?&#x2014;first steps towards individualised treatments to meet agreed targets. Clin Immunol. 2021;223:108647. doi: 10.1016/j.clim.2020.108647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108647</ArticleId><ArticleId IdType="pubmed">33310069</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634&#x2013;639. doi: 10.1016/j.amjmed.2003.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2003.12.029</ArticleId><ArticleId IdType="pubmed">15093761</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Iowa Women&#x2019;s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women&#x2019;s Health Study. Arthritis Rheum. 2004;50(1):72&#x2013;77. doi: 10.1002/art.11434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11434</ArticleId><ArticleId IdType="pubmed">14730601</ArticleId></ArticleIdList></Reference><Reference><Citation>Squance ML, Reeves GE, Tran HA. Vitamin D levels are associated with expression of SLE, but not flare frequency. Int J Rheumatol. 2014;2014:362834. doi: 10.1155/2014/362834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/362834</ArticleId><ArticleId IdType="pmc">PMC4259162</ArticleId><ArticleId IdType="pubmed">25506363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratyeva EI, Odinaeva ND, Klimov LY, Podchernyaeva NS, Ilenkova NI, Dolbnya SV, Zhekaite EK, Kuryaninova VA, Kotova YV, Tikhaya MI, Shitkovskaya EP, Bychina LV, Drepa TG, Zodbinova AE, Melyanovskaya YL, Petrova NV, Loshkova EV, Kutsev SI. Vitamin D status among children with juvenile idiopathic arthritis: a multicenter prospective, non-randomized, comparative study. Front Pediatr. 2022;26(10):915943. doi: 10.3389/fped.2022.915943.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.915943</ArticleId><ArticleId IdType="pmc">PMC9368197</ArticleId><ArticleId IdType="pubmed">35967569</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco AS, Freitas TQ, Bernardo WM, Pereira RMR. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis. Medicine. 2017;96(23):e7024. doi: 10.1097/MD.0000000000007024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007024</ArticleId><ArticleId IdType="pmc">PMC5466211</ArticleId><ArticleId IdType="pubmed">28591033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol. 2013;4(4):e33. doi: 10.1038/ctg.2013.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ctg.2013.1</ArticleId><ArticleId IdType="pmc">PMC3636524</ArticleId><ArticleId IdType="pubmed">23594800</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee IM, Manson JE, Costenbader KH. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ Clin Res ed. 2022;376:e066452. doi: 10.1136/bmj-2021-066452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066452</ArticleId><ArticleId IdType="pmc">PMC8791065</ArticleId><ArticleId IdType="pubmed">35082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou A, Selvanayagam JB, Hypp&#xf6;nen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J. 2022;43(18):1731&#x2013;1739. doi: 10.1093/eurheartj/ehab809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab809</ArticleId><ArticleId IdType="pubmed">34891159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle DD. Vitamin D: production, metabolism and mechanisms of action. In: Feingold KR, editor. Endotext. MDText.com Inc; 2021.</Citation></Reference><Reference><Citation>Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266&#x2013;281. doi: 10.1056/NEJMra070553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra070553</ArticleId><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS. Extra-renal 25-hydroxyvitamin D3&#x2013;1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007;103:316&#x2013;321. doi: 10.1016/j.jsbmb.2006.12.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2006.12.078</ArticleId><ArticleId IdType="pubmed">17368179</ArticleId></ArticleIdList></Reference><Reference><Citation>Luderer HF, Nazarian RM, Zhu ED, Demay MB. Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-&#x3b2; signaling during the inflammatory response to cutaneous injury. Endocrinology. 2013;154:16&#x2013;24. doi: 10.1210/en.2012-1579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2012-1579</ArticleId><ArticleId IdType="pmc">PMC3529380</ArticleId><ArticleId IdType="pubmed">23132743</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos HO, Martins CEC, Forbes SC, Delpino FM. A scoping review of vitamin D for nonskeletal health: a framework for evidence-based clinical practice. Clin Ther. 2023;45(5):e127&#x2013;e150. doi: 10.1016/j.clinthera.2023.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2023.03.016</ArticleId><ArticleId IdType="pubmed">37080887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilz S, Trummer C, Theiler-Schwetz V, Gr&#xfc;bler MR, Verheyen ND, Odler B, Karras SN, Zittermann A, M&#xe4;rz W. Critical appraisal of large vitamin D randomized controlled trials. Nutrients. 2022;14(2):303. doi: 10.3390/nu14020303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020303</ArticleId><ArticleId IdType="pmc">PMC8778517</ArticleId><ArticleId IdType="pubmed">35057483</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548&#x2013;1554. doi: 10.2215/CJN.0135030828.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.0135030828</ArticleId><ArticleId IdType="pmc">PMC4571149</ArticleId><ArticleId IdType="pubmed">18550652</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelsen O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients. 2010;2(5):482&#x2013;495. doi: 10.3390/nu2050482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu2050482</ArticleId><ArticleId IdType="pmc">PMC3257661</ArticleId><ArticleId IdType="pubmed">22254036</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911&#x2013;1930. doi: 10.1210/jc.2011-0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-0385</ArticleId><ArticleId IdType="pubmed">21646368</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x142;udowski P, Kos-Kud&#x142;a B, Walczak M, Fal A, Zozuli&#x144;ska-Zi&#xf3;&#x142;kiewicz D, Sieroszewski P, Peregud-Pogorzelski J, Lauterbach R, Targowski T, Lewi&#x144;ski A, Spaczy&#x144;ski R, Wielgo&#x15b; M, Pinkas J, Jackowska T, Helwich E, Mazur A, Rucha&#x142;a M, Zygmunt A, Szalecki M, Bossowski A, Czech-Kowalska J, W&#xf3;jcik M, Pyr&#x17c;ak B, &#x17b;mijewski MA, Abramowicz P, Konstantynowicz J, Marcinowska-Suchowierska E, Bleizgys A, Karras SN, Grant WB, Carlberg C, Pilz S, Holick MF, Misiorowski W. Guidelines for preventing and treating vitamin D deficiency: a 2023 update in Poland. Nutrients. 2023;15:695. doi: 10.3390/nu15030695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15030695</ArticleId><ArticleId IdType="pmc">PMC9920487</ArticleId><ArticleId IdType="pubmed">36771403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, Marcocci C, Napoli N, Rizzoli R, Giustina A. Vitamin D: dosing, levels, form, and route of administration: does one approach fit all? Rev Endocr Metab Disord. 2021;22:1201&#x2013;1218. doi: 10.1007/s11154-021-09693-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09693-7</ArticleId><ArticleId IdType="pmc">PMC8696970</ArticleId><ArticleId IdType="pubmed">34940947</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18:153&#x2013;165. doi: 10.1007/s11154-017-9424-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-017-9424-1</ArticleId><ArticleId IdType="pubmed">28516265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman KD, Dowling KG, &#x160;krab&#xe1;kov&#xe1; Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033&#x2013;1044. doi: 10.3945/ajcn.115.120873.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.120873</ArticleId><ArticleId IdType="pmc">PMC5527850</ArticleId><ArticleId IdType="pubmed">26864360</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, K&#xf6;stenberger M, Tmava Berisha A, Martucci G, Pilz S, Malle O. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74:1498&#x2013;1513. doi: 10.1038/s41430-020-0558-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-020-0558-y</ArticleId><ArticleId IdType="pmc">PMC7091696</ArticleId><ArticleId IdType="pubmed">31959942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleizgys A. Vitamin D dosing: basic principles and a brief algorithm (2021 update) Nutrients. 2021;13:4415. doi: 10.3390/nu13124415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13124415</ArticleId><ArticleId IdType="pmc">PMC8709011</ArticleId><ArticleId IdType="pubmed">34959969</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience. J Steroid Biochem Mol Biol. 2019;189:228&#x2013;239. doi: 10.1016/j.jsbmb.2018.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2018.12.010</ArticleId><ArticleId IdType="pubmed">30611908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke D, Klement RJ, Schweiger F, Schweiger B, Spitz J. Vitamin D resistance as a possible cause of autoimmune diseases: a hypothesis confirmed by a therapeutic high-dose vitamin D protocol. Front Immunol. 2021;12:655739. doi: 10.3389/fimmu.2021.655739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.655739</ArticleId><ArticleId IdType="pmc">PMC8058406</ArticleId><ArticleId IdType="pubmed">33897704</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestro MA, Moln&#xe1;r F, Mouri&#xf1;o A, Carlberg C. Vitamin D receptor 2016: novel ligands and structural insights. Expert Opin Ther Pat. 2016;26:1291&#x2013;1306. doi: 10.1080/13543776.2016.1216547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543776.2016.1216547</ArticleId><ArticleId IdType="pubmed">27454349</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997;154(Suppl):S57&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9379138</ArticleId></ArticleIdList></Reference><Reference><Citation>Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96:365&#x2013;408. doi: 10.1152/physrev.00014.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00014.2015</ArticleId><ArticleId IdType="pmc">PMC4839493</ArticleId><ArticleId IdType="pubmed">26681795</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongdee K, Charoenphandhu N. Vitamin D-enhanced duodenal calcium transport. Vitam Horm. 2015;98:407&#x2013;440. doi: 10.1016/bs.vh.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.vh.2014.12.010</ArticleId><ArticleId IdType="pubmed">25817876</ArticleId></ArticleIdList></Reference><Reference><Citation>Perwad F, Portale AA. Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23. Mol Cell Endocrinol. 2011;347:17&#x2013;24. doi: 10.1016/j.mce.2011.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2011.08.030</ArticleId><ArticleId IdType="pubmed">21914460</ArticleId></ArticleIdList></Reference><Reference><Citation>Suda T, Takahashi F, Takahashi N. Bone effects of vitamin D&#x2014;discrepancies between in vivo and in vitro studies. Arch Biochem Biophys. 2012;523:22&#x2013;29. doi: 10.1016/j.abb.2011.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2011.11.011</ArticleId><ArticleId IdType="pubmed">22107950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil &#xc1;, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab. 2018;72:87&#x2013;95. doi: 10.1159/000486536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000486536</ArticleId><ArticleId IdType="pubmed">29346788</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaus G, Meinhold-Heerlein R, Milde P, Ritz E, Mehls O. Effect of vitamin D on growth cartilage cell proliferation in vitro. Pediatr Nephrol. 1991;5:461&#x2013;466. doi: 10.1007/BF01453682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01453682</ArticleId><ArticleId IdType="pubmed">1654978</ArticleId></ArticleIdList></Reference><Reference><Citation>Idelevich A, Kerschnitzki M, Shahar R, Monsonego-Ornan E. 125(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function. PLoS ONE. 2011;6:e20772. doi: 10.1371/journal.pone.0020772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020772</ArticleId><ArticleId IdType="pmc">PMC3113808</ArticleId><ArticleId IdType="pubmed">21695192</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris HA, Turner AG, Anderson PH. Vitamin-D regulation of bone mineralization and remodelling during growth. Front Biosci (Elite Ed) 2012;4:677&#x2013;689. doi: 10.2741/409.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/409</ArticleId><ArticleId IdType="pubmed">22201904</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson CC, Davis CT, Zhu W, Bowman-Kirigin JA, Walker AE, Tai Z, Thomas KR, Donato AJ, Lesniewski LA, Li DY. Dietary vitamin d and its metabolites non-genomically stabilize the endothelium. PLoS ONE. 2015;10:e0140370. doi: 10.1371/journal.pone.0140370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140370</ArticleId><ArticleId IdType="pmc">PMC4607301</ArticleId><ArticleId IdType="pubmed">26469335</ArticleId></ArticleIdList></Reference><Reference><Citation>Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19(9):1067&#x2013;1077. doi: 10.1096/fj.04-3284com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-3284com</ArticleId><ArticleId IdType="pubmed">15985530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen PR, Kragstrup TW, Deleuran BW, Benros ME. Infections as risk factor for autoimmune diseases&#x2014;a nationwide study. J Autoimmun. 2016;74:176&#x2013;181. doi: 10.1016/j.jaut.2016.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.05.013</ArticleId><ArticleId IdType="pubmed">27267460</ArticleId></ArticleIdList></Reference><Reference><Citation>van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93&#x2013;101. doi: 10.1016/j.jsbmb.2005.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2005.06.002</ArticleId><ArticleId IdType="pubmed">16046118</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008;324:23&#x2013;33. doi: 10.1124/jpet.107.127209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.107.127209</ArticleId><ArticleId IdType="pubmed">17911375</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014;5:151. doi: 10.3389/fphys.2014.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00151</ArticleId><ArticleId IdType="pmc">PMC4000998</ArticleId><ArticleId IdType="pubmed">24795646</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10:482&#x2013;496. doi: 10.1016/j.coph.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2010.04.001</ArticleId><ArticleId IdType="pubmed">20427238</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol. 2009;70:345&#x2013;352. doi: 10.1016/j.humimm.2009.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2009.01.016</ArticleId><ArticleId IdType="pubmed">19405173</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009;20:315&#x2013;322. doi: 10.1007/s00198-008-0662-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-008-0662-7</ArticleId><ArticleId IdType="pubmed">18629569</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. doi: 10.1136/bmj.b3692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b3692</ArticleId><ArticleId IdType="pmc">PMC2755728</ArticleId><ArticleId IdType="pubmed">19797342</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C, Mu&#xf1;oz A. An update on vitamin D signaling and cancer. Semin Cancer Biol. 2022;79:217&#x2013;230. doi: 10.1016/j.semcancer.2020.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2020.05.018</ArticleId><ArticleId IdType="pubmed">32485310</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw E, Massaro N, Brockton NT. The role of vitamin D in hepatic metastases from colorectal cancer. Clin Transl Oncol. 2018;20:259&#x2013;273. doi: 10.1007/s12094-017-1735-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12094-017-1735-x</ArticleId><ArticleId IdType="pubmed">28801869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandera Merchan B, Morcillo S, Martin-Nu&#xf1;ez G, Tinahones FJ, Mac&#xed;as-Gonz&#xe1;lez M. The role of vitamin D and VDR in carcinogenesis: through epidemiology and basic sciences. J Steroid Biochem Mol Biol. 2017;167:203&#x2013;218. doi: 10.1016/j.jsbmb.2016.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2016.11.020</ArticleId><ArticleId IdType="pubmed">27913313</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, Cook NR, Lee I-M, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, D&#x2019;Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE, VITAL Research Group Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380:23&#x2013;32. doi: 10.1056/NEJMoa1811403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1811403</ArticleId><ArticleId IdType="pmc">PMC6392053</ArticleId><ArticleId IdType="pubmed">30415637</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler T, Warren Andersen S. Serum 25-hydroxyvitamin D and cancer risk: a systematic review of Mendelian randomization studies. Nutrients. 2023;15:422. doi: 10.3390/nu15020422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15020422</ArticleId><ArticleId IdType="pmc">PMC9865859</ArticleId><ArticleId IdType="pubmed">36678292</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozos I, Marginean O. Links between vitamin D deficiency and cardiovascular diseases. Biomed Res Int. 2015;2015:109275. doi: 10.1155/2015/109275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/109275</ArticleId><ArticleId IdType="pmc">PMC4427096</ArticleId><ArticleId IdType="pubmed">26000280</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimaleswaran KS, Cavadino A, Berry DJ, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a Mendelian randomisation study. Lancet Diabetes Endocrinol. 2014;2(9):719&#x2013;729. doi: 10.1016/S2213-8587(14)70113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(14)70113-5</ArticleId><ArticleId IdType="pmc">PMC4582411</ArticleId><ArticleId IdType="pubmed">24974252</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari HA, et al. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324(18):1855&#x2013;1868. doi: 10.1001/jama.2020.16909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16909</ArticleId><ArticleId IdType="pmc">PMC7656284</ArticleId><ArticleId IdType="pubmed">33170239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan KE. Pathogenesis of pediatric rheumatologic diseases. Pediatr Clin North Am. 2018;65:639&#x2013;655. doi: 10.1016/j.pcl.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2018.03.004</ArticleId><ArticleId IdType="pubmed">30031491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767&#x2013;778. doi: 10.1016/S0140-6736(07)60363-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60363-8</ArticleId><ArticleId IdType="pubmed">17336654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chistiakov DA, Savost&#x2019;anov KV, Baranov AA. Genetic background of juvenile idiopathic arthritis. Autoimmunity. 2014;47:351&#x2013;360. doi: 10.3109/08916934.2014.889119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2014.889119</ArticleId><ArticleId IdType="pubmed">24555814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19:135. doi: 10.1186/s12969-021-00629-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00629-8</ArticleId><ArticleId IdType="pmc">PMC8383464</ArticleId><ArticleId IdType="pubmed">34425842</ArticleId></ArticleIdList></Reference><Reference><Citation>Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2022;74:553&#x2013;569. doi: 10.1002/art.42037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42037</ArticleId><ArticleId IdType="pmc">PMC10161784</ArticleId><ArticleId IdType="pubmed">35233993</ArticleId></ArticleIdList></Reference><Reference><Citation>Stawicki MK, Abramowicz P, G&#xf3;ralczyk A, M&#x142;y&#x144;czyk J, Kondratiuk A, Konstantynowicz J. Prevalence of vitamin D deficiency in patients treated for juvenile idiopathic arthritis and potential role of methotrexate: a preliminary study. Nutrients. 2022;14:1645. doi: 10.3390/nu14081645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14081645</ArticleId><ArticleId IdType="pmc">PMC9027140</ArticleId><ArticleId IdType="pubmed">35458206</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch SL, Rosenberg AM, Vatanparast H. Vitamin D and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2018;16:34. doi: 10.1186/s12969-018-0250-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-018-0250-0</ArticleId><ArticleId IdType="pmc">PMC5956785</ArticleId><ArticleId IdType="pubmed">29769136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisar MK, Masood F, Cookson P, Sansome A, Ost&#xf6;r AJK. What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence. Clin Rheumatol. 2013;32:729&#x2013;734. doi: 10.1007/s10067-012-2159-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-012-2159-1</ArticleId><ArticleId IdType="pubmed">23296646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaroni-Clarke RC, Munro JE, Pezic A, Cobb JE, Akikusa JD, Allen RC, Dwyer T, Ponsonby AL, Ellis JA. Association of increased sun exposure over the life-course with a reduced risk of juvenile idiopathic arthritis. Photochem Photobiol. 2019;95:867&#x2013;873. doi: 10.1111/php.13045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/php.13045</ArticleId><ArticleId IdType="pubmed">30378692</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen SU, Pipper CB, Alberdi-Saugstrup M, Nielsen S, Cohen A, Lundqvist M, Thygesen LC, Ascherio A, Svensson J. No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study. Scand J Rheumatol. 2017;46:104&#x2013;111. doi: 10.1080/03009742.2016.1178325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009742.2016.1178325</ArticleId><ArticleId IdType="pubmed">27460412</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SLN, Mitchell RE, Sharp GC, Ramanan AV, Relton CL. Vitamin D levels and risk of juvenile idiopathic arthritis: a Mendelian randomization study. Arthritis Care Res (Hoboken) 2023;75:674&#x2013;681. doi: 10.1002/acr.24815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24815</ArticleId><ArticleId IdType="pubmed">34748291</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T, Zhang Y, Luo C, Liu M, Xu L, Tang X. Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: an open-label, prospective, randomized controlled trial. Exp Ther Med. 2019;18:4921&#x2013;4926. doi: 10.3892/etm.2019.8133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.8133</ArticleId><ArticleId IdType="pmc">PMC6880388</ArticleId><ArticleId IdType="pubmed">31798713</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi M, Mullick MAS, Nandy A, Samanta M, Sarkar S, Sabui TK. Evaluation of vitamin D profile in juvenile idiopathic arthritis. Mod Rheumatol. 2022;32:792&#x2013;796. doi: 10.1093/mr/roab053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mr/roab053</ArticleId><ArticleId IdType="pubmed">34910210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengler C, Zink J, Klotsche J, Niewerth M, Liedmann I, Horneff G, Kessel C, Ganser G, Thon A, Haas J-P, Hospach A, Weller-Heinemann F, Heiligenhaus A, Foell D, Zink A, Minden K. Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis&#x2014;data from a German inception cohort. Arthritis Res Ther. 2018;20:276. doi: 10.1186/s13075-018-1765-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1765-y</ArticleId><ArticleId IdType="pmc">PMC6293517</ArticleId><ArticleId IdType="pubmed">30545399</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;omak E, Do&#x11f;an &#xc7;S, Uslu-G&#xf6;k&#xe7;eo&#x11f;lu A, Akba&#x15f; H, &#xd6;zdem S, Koyun M, Akman S. Association between vitamin D deficiency and disease activity in juvenile idiopathic arthritis. Turk J Pediatr. 2014;56:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">26388593</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini F, Falcini F, Stagi S, Fabbri S, Ciuffi S, Rigante D, Cerinic MM, Brandi ML. Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis. Sci Rep. 2020;10:17550. doi: 10.1038/s41598-020-74861-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74861-9</ArticleId><ArticleId IdType="pmc">PMC7567873</ArticleId><ArticleId IdType="pubmed">33067526</ArticleId></ArticleIdList></Reference><Reference><Citation>Da&#x11f;deviren-&#xc7;ak&#x131;r A, Arvas A, Barut K, G&#xfc;r E, Kasap&#xe7;opur &#xd6;. Serum vitamin D levels during activation and remission periods of patients with juvenile idiopathic arthritis and familial Mediterranean fever. Turk J Pediatr. 2016;58:125&#x2013;131. doi: 10.24953/turkjped.2016.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.24953/turkjped.2016.02.001</ArticleId><ArticleId IdType="pubmed">27976551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouaddi I, Rostom S, El Badri D, Hassani A, Chkirate B, Abouqal R, Amine B, Hajjaj-Hassouni N. Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis. BMC Musculoskelet Disord. 2014;15:115. doi: 10.1186/1471-2474-15-115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-15-115</ArticleId><ArticleId IdType="pmc">PMC3973605</ArticleId><ArticleId IdType="pubmed">24690195</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17:515&#x2013;532. doi: 10.1038/s41584-021-00668-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00668-1</ArticleId><ArticleId IdType="pmc">PMC8982275</ArticleId><ArticleId IdType="pubmed">34345022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA, UK JSLE Study Group Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25:1542&#x2013;1550. doi: 10.1177/0961203316644333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316644333</ArticleId><ArticleId IdType="pmc">PMC5089221</ArticleId><ArticleId IdType="pubmed">27147622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamal SM, Fouad N, Yosry N, Badr W, Sobhy N. Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: a multi-center comparative study. Arch Rheumatol. 2022;37:280&#x2013;287. doi: 10.46497/ArchRheumatol.2022.8888.</Citation><ArticleIdList><ArticleId IdType="doi">10.46497/ArchRheumatol.2022.8888</ArticleId><ArticleId IdType="pmc">PMC9377179</ArticleId><ArticleId IdType="pubmed">36017206</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander T, Hedrich CM. Systemic lupus erythematosus&#x2014;are children miniature adults? Clin Immunol. 2022;234:108907. doi: 10.1016/j.clim.2021.108907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108907</ArticleId><ArticleId IdType="pubmed">34890808</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner HI, Gladman DD, Iba&#xf1;ez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58:556&#x2013;562. doi: 10.1002/art.23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23204</ArticleId><ArticleId IdType="pubmed">18240232</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Shanab AM, Kholoussi S, Kandil R, Dorgham D. Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus. Lupus. 2021;30:459&#x2013;464. doi: 10.1177/0961203320973068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320973068</ArticleId><ArticleId IdType="pubmed">33183127</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagi S, Cavalli L, Bertini F, de Martino M, Cerinic MM, Brandi ML, Falcini F. Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study. Lupus. 2014;23:1059&#x2013;1065. doi: 10.1177/0961203314532564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314532564</ArticleId><ArticleId IdType="pubmed">24731961</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabra SAA, Abdelnabi HH, Darwish NFM, El-Barbary AM, AbdelGhafar MT, Abu-Zaid MH. Juvenile lupus and serum vitamin D levels: a cross-sectional study. Lupus. 2020;29:1752&#x2013;1758. doi: 10.1177/0961203320957721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320957721</ArticleId><ArticleId IdType="pubmed">32924829</ArticleId></ArticleIdList></Reference><Reference><Citation>Caetano M, Terreri MT, Ortiz T, Pinheiro M, Souza F, Sarni R. Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation. Clin Rheumatol. 2015;34:2065&#x2013;2070. doi: 10.1007/s10067-015-3011-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-3011-1</ArticleId><ArticleId IdType="pubmed">26227163</ArticleId></ArticleIdList></Reference><Reference><Citation>Peracchi OAB, Terreri MTRA, Munekata RV, Len CA, Sarni ROS, Lazaretti-Castro M, Hil&#xe1;rio MOE. Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus. Braz J Med Biol Res. 2014;47:721&#x2013;726. doi: 10.1590/1414-431x20143948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x20143948</ArticleId><ArticleId IdType="pmc">PMC4165300</ArticleId><ArticleId IdType="pubmed">25055165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RMR. Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken) 2016;68:91&#x2013;98. doi: 10.1002/acr.22621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22621</ArticleId><ArticleId IdType="pubmed">25988278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima GL, Paupitz JA, Aikawa NE, Alvarenga JC, Pereira RMR. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT. Osteoporos Int. 2018;29:587&#x2013;594. doi: 10.1007/s00198-017-4316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-017-4316-5</ArticleId><ArticleId IdType="pubmed">29152675</ArticleId></ArticleIdList></Reference><Reference><Citation>Beukelman T, Xie F, Foeldvari I. Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States. J Scleroderma Relat Disord. 2018;3:189&#x2013;190. doi: 10.1177/2397198318763701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2397198318763701</ArticleId><ArticleId IdType="pmc">PMC8892864</ArticleId><ArticleId IdType="pubmed">35382241</ArticleId></ArticleIdList></Reference><Reference><Citation>Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clin Rheumatol. 2018;37:2103&#x2013;2111. doi: 10.1007/s10067-018-4182-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4182-3</ArticleId><ArticleId IdType="pmc">PMC6061074</ArticleId><ArticleId IdType="pubmed">29961234</ArticleId></ArticleIdList></Reference><Reference><Citation>Vona R, Giovannetti A, Gambardella L, Malorni W, Pietraforte D, Straface E. Oxidative stress in the pathogenesis of systemic scleroderma: an overview. J Cell Mol Med. 2018;22:3308&#x2013;3314. doi: 10.1111/jcmm.13630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13630</ArticleId><ArticleId IdType="pmc">PMC6010858</ArticleId><ArticleId IdType="pubmed">29664231</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal P, Schulz J-N, Blumbach K, Andreasson K, Heineg&#xe5;rd D, Paulsson M, Mauch C, Eming SA, Eckes B, Krieg T. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Matrix Biol. 2013;32:325&#x2013;331. doi: 10.1016/j.matbio.2013.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2013.02.010</ArticleId><ArticleId IdType="pubmed">23507196</ArticleId></ArticleIdList></Reference><Reference><Citation>van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P. Unraveling SSc pathophysiology; the Myofibroblast. Front Immunol. 2018;9:2452. doi: 10.3389/fimmu.2018.02452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02452</ArticleId><ArticleId IdType="pmc">PMC6242950</ArticleId><ArticleId IdType="pubmed">30483246</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens AM, Kanaan SB, Torok KS, Medsger TA, Mayes MD, Reveille JD, Klein-Gitelman M, Reed AM, Lee T, Li SC, Henstorf G, Luu C, Aydelotte T, Nelson JL. Brief report: HLA-DRB1, DQA1, and DQB1 in juvenile-onset systemic sclerosis. Arthritis Rheumatol. 2016;68:2772&#x2013;2777. doi: 10.1002/art.39765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39765</ArticleId><ArticleId IdType="pmc">PMC6594690</ArticleId><ArticleId IdType="pubmed">27214100</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens AM, Torok KS, Li SC, Taber SF, Lu TT, Zulian F. Immunopathogenesis of juvenile systemic sclerosis. Front Immunol. 2019;10:1352. doi: 10.3389/fimmu.2019.01352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01352</ArticleId><ArticleId IdType="pmc">PMC6603145</ArticleId><ArticleId IdType="pubmed">31293569</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. 2018;65:757&#x2013;781. doi: 10.1016/j.pcl.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2018.04.002</ArticleId><ArticleId IdType="pubmed">30031497</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Kasapcopur O, Feitosa K, de Oliveira S, Pilkington C, Toplak N, van Royen A, Saad Magalhaes C, Vastert SJ, Wulffraat N, Zulian F. Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford) 2021;60:1651&#x2013;1658. doi: 10.1093/rheumatology/keaa584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa584</ArticleId><ArticleId IdType="pubmed">33147624</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Klotsche J, Torok KS, Kasapcopur O, Adrovic A, Stanevicha V, Terreri MT, Alexeeva E, Katsicas M, Cimaz R, Kostik M, Lehman T, Sifuentes-Giraldo W-A, Smith V, Sztajnbok F, Avcin T, Jose Santos M, Moll M, Nemcova D, Battagliotti C, Eleftheriou D, Janarthanan M, Kallinich T, Anton J, Minden K, Nielsen S, Uziel Y, Helmus N. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. J Scleroderma Relat Disord. 2019;4:49&#x2013;61. doi: 10.1177/2397198318790494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2397198318790494</ArticleId><ArticleId IdType="pmc">PMC8922583</ArticleId><ArticleId IdType="pubmed">35382144</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrovic A, Karatemiz G, Esatoglu SN, Yildiz M, Sahin S, Barut K, Ugurlu S, Hatemi G, Kasapcopur O, Seyahi E. Juvenile and adult-onset scleroderma: different clinical phenotypes. Semin Arthritis Rheum. 2023;60:152197. doi: 10.1016/j.semarthrit.2023.152197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2023.152197</ArticleId><ArticleId IdType="pubmed">37031645</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I. Update on pediatric systemic sclerosis: similarities and differences from adult disease. Curr Opin Rheumatol. 2008;20:608&#x2013;612. doi: 10.1097/BOR.0b013e3283103cfd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e3283103cfd</ArticleId><ArticleId IdType="pubmed">18698186</ArticleId></ArticleIdList></Reference><Reference><Citation>An L, Sun MH, Chen F, Li JR. Vitamin D levels in systemic sclerosis patients: a meta-analysis. Drug Des Devel Ther. 2017;11:3119&#x2013;3125. doi: 10.2147/DDDT.S144860.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S144860</ArticleId><ArticleId IdType="pmc">PMC5667779</ArticleId><ArticleId IdType="pubmed">29138534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio-Barros MM, Takayama L, Sampaio-Barros PD, Bonf&#xe1; E, Pereira RM. Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findings. Rev Bras Reumatol Engl Ed. 2016;56(4):337&#x2013;344. doi: 10.1016/j.rbre.2016.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbre.2016.05.006</ArticleId><ArticleId IdType="pubmed">27476627</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, Stanevicha V, Sztajnbok F, Anton J, Feldman B, Alexeeva E, Katsicas M, Smith V, Avcin T, Marrani E, Kostik M, Lehman T, Sifuentes-Giraldo W-A, Vasquez-Canizares N, Appenzeller S, Janarthanan M, Moll M, Nemcova D, Patwardhan A, Santos MJ, Sawhney S, Schonenberg-Meinema D, Battagliotti C, Berntson L, Bica B, Brunner J, Costa-Reis P, Eleftheriou D, Harel L, Horneff G, Kaiser D, Kallinich T, Lazarevic D, Minden K, Nielsen S, Nuruzzaman F, Uziel Y, Helmus N, Torok KS. Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in an expanded international cohort. Arthritis Care Res (Hoboken) 2022;74:1575&#x2013;1584. doi: 10.1002/acr.24609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24609</ArticleId><ArticleId IdType="pubmed">33787070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinjo SK, Bonf&#xe1; E, de Falco CV, Pereira RM. Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency. Rheumatol Int. 2011;31(8):1075&#x2013;1080. doi: 10.1007/s00296-010-1421-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-010-1421-6</ArticleId><ArticleId IdType="pubmed">20336459</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J Intern Med. 2016;280:24&#x2013;38. doi: 10.1111/joim.12444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12444</ArticleId><ArticleId IdType="pmc">PMC4914449</ArticleId><ArticleId IdType="pubmed">27028907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson C, Piguet V, Choy E. The pathogenesis of dermatomyositis. Br J Dermatol. 2018;179:1256&#x2013;1262. doi: 10.1111/bjd.15607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.15607</ArticleId><ArticleId IdType="pubmed">28542733</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed AM, Pachman L, Ober C. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501. Hum Immunol. 1991;32:235&#x2013;240. doi: 10.1016/0198-8859(91)90085-n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0198-8859(91)90085-n</ArticleId><ArticleId IdType="pubmed">1783570</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker JN, Engel WK. Mechanisms of muscle injury in idiopathic inflammatory myopathy. N Engl J Med. 1973;289:107&#x2013;108. doi: 10.1056/NEJM197307122890223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197307122890223</ArticleId><ArticleId IdType="pubmed">4710399</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AKC, Lam JM, Alobaida S, Leong KF, Wong AHC. Juvenile dermatomyositis: advances in pathogenesis, assessment, and management. Curr Pediatr Rev. 2021;17:273&#x2013;287. doi: 10.2174/1573396317666210426105045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573396317666210426105045</ArticleId><ArticleId IdType="pubmed">33902423</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartier P, Gherardi RK. Juvenile dermatomyositis. Handb Clin Neurol. 2013;113:1457&#x2013;1463. doi: 10.1016/B978-0-444-59565-2.00014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-59565-2.00014-9</ArticleId><ArticleId IdType="pubmed">23622367</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson AB, Thierry-Palmer M, Gibson KL, Rabinovich CE. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J Pediatr. 2012;160(2):297&#x2013;302. doi: 10.1016/j.jpeds.2011.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2011.08.011</ArticleId><ArticleId IdType="pmc">PMC3258326</ArticleId><ArticleId IdType="pubmed">21924736</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG, with the Childhood Myositis Heterogeneity Collaborative Study Group The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013;92:25&#x2013;41. doi: 10.1097/MD.0b013e31827f264d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0b013e31827f264d</ArticleId><ArticleId IdType="pmc">PMC4580479</ArticleId><ArticleId IdType="pubmed">23263716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Cheng H, Liang Y, Ding T, Yan C, Gao C, Wen H. Decreased serum 25-(OH)-D level associated with muscle enzyme and myositis specific autoantibodies in patients with idiopathic inflammatory myopathy. Front Immunol. 2021;12:642070. doi: 10.3389/fimmu.2021.642070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.642070</ArticleId><ArticleId IdType="pmc">PMC8082096</ArticleId><ArticleId IdType="pubmed">33936057</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Luigi L, Sottili M, Antinozzi C, Vannelli GB, Romanelli F, Riccieri V, Valesini G, Lenzi A, Crescioli C. The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies. PLoS ONE. 2013;8:e77745. doi: 10.1371/journal.pone.0077745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077745</ArticleId><ArticleId IdType="pmc">PMC3813757</ArticleId><ArticleId IdType="pubmed">24204948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatemi G, U&#xe7;ar D, Uyguno&#x11f;lu U, Yazici H, Yazici Y. Beh&#xe7;et syndrome. Rheum Dis Clin North Am. 2023;49(3):585&#x2013;602. doi: 10.1016/j.rdc.2023.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2023.03.010</ArticleId><ArticleId IdType="pubmed">37331734</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto IG, Alabau JLC. Immunopathogenesis of Beh&#xe7;et disease. Curr Rheumatol Rev. 2020;16(1):12&#x2013;20. doi: 10.2174/1573397115666190415142426.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573397115666190415142426</ArticleId><ArticleId IdType="pubmed">30987569</ArticleId></ArticleIdList></Reference><Reference><Citation>Batu ED. Diagnostic/classification criteria in pediatric Beh&#xe7;et's disease. Rheum Int. 2019;39(1):37&#x2013;46. doi: 10.1007/s00296-018-4208-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-018-4208-9</ArticleId><ArticleId IdType="pubmed">30430200</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Chiang BL, Yang YH. Clinical manifestations and management of pediatric Beh&#xe7;et's disease. Clin Rev Allergy Immunol. 2021;61(2):171&#x2013;180. doi: 10.1007/s12016-020-08809-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08809-2</ArticleId><ArticleId IdType="pubmed">32767171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettiol A, Prisco D, Emmi G. Beh&#xe7;et: the syndrome. Rheumatology (Oxford) 2020;59(Suppl 3):iii101&#x2013;iii107. doi: 10.1093/rheumatology/kez626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kez626</ArticleId><ArticleId IdType="pubmed">32348523</ArticleId></ArticleIdList></Reference><Reference><Citation>Kone-Paut I, Bernard JL. La maladie de Beh&#xe7;et chez l'enfant en France [Beh&#xe7;et disease in children in France] Arch Pediatr. 1993;50(7):561&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">8002718</ArticleId></ArticleIdList></Reference><Reference><Citation>Can M, Gunes M, Haliloglu OA, Haklar G, Inan&#xe7; N, Yavuz DG, Direskeneli H. Effect of vitamin D deficiency and replacement on endothelial functions in Beh&#xe7;et's disease. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S57&#x2013;S61.</Citation><ArticleIdList><ArticleId IdType="pubmed">23020973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemzadeh K, Rezazadeh M, Eftekhari A, Esparham A, Jokar MH, Kheradmand HR. Vitamin D levels in patients with Behcet's disease: a systematic review and meta-analysis. Curr Rheumatol Rev. 2022;18(3):203&#x2013;211. doi: 10.2174/1573397118666220218112841.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573397118666220218112841</ArticleId><ArticleId IdType="pubmed">35184713</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar HS, Taha FM, Fouad S, Ibrahim FA, El Gendy A, Bassyouni IH, El-Shazly R. The association between vitamin D levels and oxidative stress markers in Egyptian Behcet's disease patients. Orphanet J Rare Dis. 2022;17(1):264. doi: 10.1186/s13023-022-02416-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02416-4</ArticleId><ArticleId IdType="pmc">PMC9287946</ArticleId><ArticleId IdType="pubmed">35841050</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ng&#xf6;r &#x15e;, G&#xf6;kdemir G, &#xc7;i&#xe7;ek YG, Topal &#x130;O, Canat D. The effect of 25(OH)D on endothelial and immunological markers in Beh&#xe7;et's disease. J Dermatol Treat. 2016;27(3):254&#x2013;259. doi: 10.3109/09546634.2015.1093585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09546634.2015.1093585</ArticleId><ArticleId IdType="pubmed">26368304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Beh&#xe7;et's disease. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S50&#x2013;S57.</Citation><ArticleIdList><ArticleId IdType="pubmed">20868571</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Wang C, Ye Z, Xiao X, Kijlstra A, Yang P. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Beh&#xe7;et's disease. Invest Ophthalmol Vis Sci. 2012;53(10):6434&#x2013;6441. doi: 10.1167/iovs.12-10398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.12-10398</ArticleId><ArticleId IdType="pubmed">22918640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Su G, Du L, Zhou Q, Li F, Chi W, Liu S, Zhang M, Zuo X, Yang P. Higher 25-hydroxyvitamin D level is associated with increased risk for Beh&#xe7;et's disease. Clin Nutr. 2021;40(2):518&#x2013;524. doi: 10.1016/j.clnu.2020.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.05.049</ArticleId><ArticleId IdType="pubmed">32593521</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattorno M, Hofer M, Federici S, et al. Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO). Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025&#x2013;1032. doi: 10.1136/annrheumdis-2019-215048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215048</ArticleId><ArticleId IdType="pubmed">31018962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausmann JS, Dedeoglu F. Autoinflammatory diseases in pediatrics. Dermatol Clin. 2013;31(3):481&#x2013;494. doi: 10.1016/j.det.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.det.2013.04.003</ArticleId><ArticleId IdType="pubmed">23827250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Sepp&#xe4;nen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42(7):1473&#x2013;1507. doi: 10.1007/s10875-022-01289-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01289-3</ArticleId><ArticleId IdType="pmc">PMC9244088</ArticleId><ArticleId IdType="pubmed">35748970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausmann JS. Targeting cytokines to treat autoinflammatory diseases. Clin Immunol. 2019;206:23&#x2013;32. doi: 10.1016/j.clim.2018.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.10.016</ArticleId><ArticleId IdType="pubmed">30394352</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamid M, Agbaria K, Mahamid A, Nseir W. Vitamin D linked to PFAPA syndrome. Int J Pediatr Otorhinolaryngol. 2013;77(3):362&#x2013;364. doi: 10.1016/j.ijporl.2012.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2012.11.027</ArticleId><ArticleId IdType="pubmed">23246421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbanto&#x11f;lu A, Nalbanto&#x11f;lu B. Vitamin D deficiency as a risk factor for PFAPA syndrome. Int J Pediatr Otorhinolaryngol. 2019;121:55&#x2013;57. doi: 10.1016/j.ijporl.2019.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2019.02.047</ArticleId><ArticleId IdType="pubmed">30870794</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagi S, Bertini F, Rigante D, Falcini F. Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Int J Pediatr Otorhinolaryngol. 2014;78(6):964&#x2013;968. doi: 10.1016/j.ijporl.2014.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2014.03.026</ArticleId><ArticleId IdType="pubmed">24746456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotfy HM, Marzouk H, Farag Y, Salah A, Taher H, Nabih M, Rashed L, El-Garf K. Serum vitamin D level in Egyptian children with Familial Mediterranean fever. Immunol Lett. 2017;185:74&#x2013;78. doi: 10.1016/j.imlet.2017.03.00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2017.03.00121</ArticleId><ArticleId IdType="pubmed">28341008</ArticleId></ArticleIdList></Reference><Reference><Citation>Onur H, Aral H, Arica V, Bercem GA, Kasapcopur O. Vitamin D levels in children with familial Mediterranean fever. Pediatr Rheumatol Online J. 2016;14(1):28. doi: 10.1186/s12969-016-0089-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-016-0089-1</ArticleId><ArticleId IdType="pmc">PMC4848823</ArticleId><ArticleId IdType="pubmed">27121284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazem Y, Zarouk WA, Hamed K, Tosson AMS, Essa HA, El-Bassyouni HT. The effect of anti-inflammatory diet and vitamin D supplementation on the amelioration of the clinical status and cognitive functions of familial Mediterranean fever patients. Kobe J Med Sci. 2021;66(5):E159&#x2013;E165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212802</ArticleId><ArticleId IdType="pubmed">34001682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>